Chemoinformaics analysis of urs-12-en-28-oic acid
| Molecular Weight | 456.711 | nRot | 1 |
| Heavy Atom Molecular Weight | 408.327 | nRig | 27 |
| Exact Molecular Weight | 456.36 | nRing | 5 |
| Solubility: LogS | -4.383 | nHRing | 0 |
| Solubility: LogP | 6.083 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 84.5121 |
| nHD | 2 | BPOL | 49.0219 |
| QED | 0.414 |
| Synth | 4.723 |
| Natural Product Likeliness | 3.186 |
| NR-PPAR-gamma | 0.89 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.011 |
| CACO-2 | -5.221 |
| MDCK | 0.0000139 |
| BBB | 0.719 |
| PPB | 0.988431 |
| VDSS | 0.815 |
| FU | 0.0224174 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.434 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.95 |
| CYP2c9-inh | 0.113 |
| CYP2c9-sub | 0.701 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.276 |
| CYP3a4-inh | 0.137 |
| CYP3a4-sub | 0.404 |
| CL | 3.671 |
| T12 | 0.017 |
| hERG | 0.001 |
| Ames | 0.012 |
| ROA | 0.183 |
| SkinSen | 0.013 |
| Carcinogencity | 0.031 |
| EI | 0.137 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.817 |
| Antiviral | No |
| Prediction | 0.750755 |